Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.

Shear, Neil H; Paul, Carle; Blauvelt, Andrew; Gooderham, Melinda; Leonardi, Craig; Reich, Kristian; Ohtsuki, Mamitaro; Pangallo, Beth; Xu, Wen; Ball, Susan; Ridenour, Terri; Torisu-Itakura, Hitoe; Agada, Noah; Mallbris, Lotus

Shear, Neil H; Paul, Carle; Blauvelt, Andrew; Gooderham, Melinda; Leonardi, Craig; Reich, Kristian; Ohtsuki, Mamitaro; Pangallo, Beth; Xu, Wen; Ball, Susan; Ridenour, Terri; Torisu-Itakura, Hitoe; Agada, Noah; Mallbris, Lotus.

J Drugs Dermatol ; 17(2): 200-206, 2018 Feb 01.

Article in En | MEDLINE | ID: mdl-29462229

Subject(s)

Antibodies, Monoclonal, Humanized/adverse effects; Clinical Trials as Topic/methods; Dermatologic Agents/adverse effects; Injection Site Reaction/epidemiology; Antibodies, Monoclonal, Humanized/administration & dosage; Dermatologic Agents/administration & dosage; Female; Humans; Injection Site Reaction/diagnosis; Male

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Clinical Trials as Topic / Dermatologic Agents / Antibodies, Monoclonal, Humanized / Injection Site Reaction Type of study: Clinical_trials / Diagnostic_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2018 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links